IL6 and type 2 diabetes mellitus: The inflammatory response leads to increased pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α), mirroring the systemic inflammation seen in type 2 diabetes (T2D) [10].